Cited by 41Nanoparticle-Based Drug DeliveryMangiferin and Mango ExtractsAdvanced Drug Delivery Systems

Mangiferin-Loaded Polymeric Nanoparticles: Optical Characterization, Effect of Anti-topoisomerase I, and Cytotoxicity

Open access
Razura-Carmona, Francisco Fabian, Pérez-Larios, Alejandro, González-Silva, Napoleón, Herrera-Martínez, Mayra, Medina-Torres, Luis, Sáyago-Ayerdi, Sonia Guadalupe, Sánchez-Burgos, Jorge Alberto·2019·Cancers

Abstract

Mangiferin is an important xanthone compound presenting various biological activities. The objective of this study was to develop, characterize physicochemical properties, and evaluate the anti-topoisomerase activity of poly(lactic-co-glycolic acid) (PLGA) nanoparticles containing mangiferin. The nanoparticles were developed by the emulsion solvent evaporation method and the optimal formulation was obtained with a response surface methodology (RSM); this formulation showed a mean size of 176.7 ± 1.021 nm with a 0.153 polydispersibility index (PDI) value, and mangiferin encapsulation efficiency was about 55%. The optimal conditions (6000 rpm, 10 min, and 300 μg of mangiferin) obtained 77% and the highest entrapment efficiency (97%). The in vitro release profile demonstrated a gradual release of mangiferin from 15 to 180 min in acidic conditions (pH 1.5). The fingerprint showed a modification in the maximum absorption wavelength of both the polymer and the mangiferin. Results of anti-toposiomerase assay showed that the optimal formulation (MG4, 25 µg/mL) had antiproliferative activity. High concentrations (2500 µg/mL) of MG4 showed non-in vitro cytotoxic effect on BEAS 2B and HEPG2. Finally, this study showed an encapsulation process with in vitro gastric digestion resistance (1.5 h) and without interfering with the metabolism of healthy cells and their biological activity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers11121965

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Multiple delivery approaches (nanostructured lipid carriers, polymeric and chitosan-based nanogels, phospholipid complexes, targeted nanoparticles) have improved MGF exposure in preclinical systems.

    “Multiple approaches have improved exposure in preclinical systems, including nanostructured lipid carriers, polymeric and chitosan-based nanogels, phospholipid complexes (2,172,173), and targeted nanoparticles designed to enhance intestinal uptake or lymphatic transport and to stabilize MGF against rapid metabolism (172,174-176).”

    From Mangiferin in human disease: Multifaceted mechanisms and applications (Review) (2026) · cites this paper as [172]

    The Methods and Results describe mangiferin-loaded PLGA nanoparticles with controlled release under simulated acidic gastrointestinal conditions. They do not show improved mangiferin exposure in a preclinical system or demonstrate enhanced intestinal uptake, lymphatic transport, or protection against rapid metabolism. The other delivery approaches listed in the citing sentence are not findings of this study. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [17]Busatto C.A. Helbling I. Casis N. Luna N. Estenoz D.A. Microesferas biodegradables de PLGA para la liberación controlada de progesterona Proceedings of the 13st Congresso da Sociedade Latino Americana de Biomateriais, Orgãos Artificiais e Engenharia de Tecidos—SLABO Foz do Iguaçu, Brazil 24–27 August 2016
  2. [32]Thomas M. Ultraviolet and Visible Spectroscopy 2nd ed. John Wiley & Sons New York, NY, USA 1996 172

Cited by

Sorted by citations

Authors
Razura-Carmona, F. F., Pérez-Larios, A., González-Silva, N., Herrera-Martínez, M., Medina-Torres, L., Sáyago-Ayerdi, S. G., & Sánchez-Burgos, J. A.
Affiliations
  • Tecnológico Nacional de México/I.T. Tepic, Laboratorio Integran de Investigación en Alimentos, Lagos del Country, Tepic CP 63175, Nayarit, Mexico
  • Division of Agricultural Sciences and Engineering, University Center of the Altos, University of Guadalajara, Tepatitlán de Morelos CP 47620, Jalisco, Mexico
  • Universidad de la Cañada (MX)
  • Facultad de Química, Universidad Nacional Autónoma de México, México D.F. CP 04510, Mexico
  • Tecnológico Nacional de México (MX)
Corresponding author
Sánchez-Burgos, Jorge Alberto
Venue
Cancers
Publisher
MDPI AG
Published
2019-12-06
Volume
11
Issue
12
Pages
1965
ISSN
2072-6694 (ISSN-L)
OpenAlex
W2994331481
Cited by
40
References
59
Citations by year
2026: 2 · 2025: 11 · 2024: 9 · 2023: 8 · 2022: 5 · 2021: 4 · 2020: 1
FWCI
0.71
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Universidad de Guadalajara
  • Consejo Nacional de Ciencia y Tecnología (787023)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Complementary and alternative medicine › Mangiferin and Mango Extracts
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
mangiferin, PLGA nanoparticles, polymeric nanoparticles, xanthones, topoisomerase I inhibition, anticancer activity, encapsulation efficiency, in vitro drug release, cytotoxicity, BEAS-2B, HepG2 cells, emulsion solvent evaporation, response surface methodology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review